High-Yield Hitters: Cutaneous Manifestations of Systemic Disease
Cutaneous Manifestations of Systemic Disease Do you feel comfortable recognizing retiform purpura and initiating the work up to identify the underlying etiology? What can cause “cellulitis” on the breast that does not get better with antibiotics? What are the most common drug culprits triggering eczematous eruptions in the elderly and stubborn psoriasis? What medication is associated with vulvovaginal pyoderma gangrenosum? If these cas …
Cutaneous Manifestations of Systemic Disease
Hyperhidrosis: Available Treatments and New Innovations
HyperhidrosisWhat is Hyperhidrosis (HH)? Primary HH is defined as excessive, bilateral, and generally symmetrical sweating at abnormal levels unprompted by activity or environment. Hyperhidrosis is characterized by abnormal sweating beyond what is needed for thermoregulation. It is not a normal physiologic response. Nearly 15 million people in the United States suffer from hyperhidrosis and half of thos …
Hyperhidrosis
JDD March 2021 Issue Highlights: From OTC Products for Acne to MMS for Genital Skin Cancer
JDD MARCH 2021 ISSUEThe March issue of the Journal of Drugs in Dermatology features an outstanding line-up of articles with topics ranging from OTC products for acne to Mohs Micrographic Surgery for genital skin cancer. Straight from the JDD Editor’s desk, we share this month’s issue highlights: Advisors agreed that OTC products and skincare recommendations, in addition to the use of prescription medications, …
JDD MARCH 2021 ISSUE
Severe Oral Mucositis: A Rare Adverse Event of Pembrolizumab
Oral MucositisTreatment of malignancy with anti-programmed cell death 1 (PD-1) immune checkpoint inhibitors can cause mucocutaneous side effects resulting from T cell activation. Due to their recent development, the full side effect profile remains to be fully elucidated, however dermatologic adverse events are most common. The main oral toxicities of these immune checkpoint inhibitors include: xerostomia, dysg …
Oral Mucositis
Easing the Management of Atopic Dermatitis
Atopic DermatitisDr. Friedman, jack of many trades, Professor and Interim Chair of Dermatology at George Washington University provided an excellent overview of ways to achieve victory over atopic dermatitis (AD). This expert discussion took place during the ODAC Inflammatory Diseases Symposium on December 3, 2020. How could we possibly cover atopic dermatitis in 20 minutes? Well, Dr. Friedman skillfully led us …
Atopic Dermatitis
error

Enjoy this blog? Please spread the word :)